Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04614389 · ClinicalTrials.gov registry record · NA

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

A NA study, sponsored by University of Southern California.

Terminated
Registry status
NA
Development phase
20
Enrollment target

NCT04614389: Clinical Trial NA study, sponsored by University of Southern California.

NCT04614389 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04614389, a NA study, was terminated before completion, sponsored by University of Southern California.

TERMINATED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Our overall hypothesis is that Contrast-enhanced ultrasound (CEUS) and Shear Wave Elastography (SWE) will allow for high diagnostic accuracy of benign and malignant thyroid nodules, which will correlate with and complement the ACR TI-RADS classification system, allowing for more accurate diagnosis of benign and malignant thyroid nodules.

Primary Outcome

Kappa analysis will be used to assess the agreement between the two radiologists visual assessment result. The rating result of each radiologist will be compared to the pathological result using Kappa analysis as well.

Interventions

  • OTHER Contrast-enhanced ultrasound
  • OTHER Shear Wave Elastography
  • DEVICE Sequoia System

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2019-09-04
Est. Completion 2021-07-07
Phase NA
University of Southern California

617 total trials

Why NCT04614389 stopped before completion

NCT04614389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Contrast-enhanced ultrasound is the first listed.

NCT04614389 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04614389 about?

NCT04614389 is a clinical study titled "Utility of Contrast-Enhanced Sonography and Shear Wave Elastography". Our overall hypothesis is that Contrast-enhanced ultrasound (CEUS) and Shear Wave Elastography (SWE) will allow for high diagnostic accuracy of benign and malignant thyroid nodules, which will correlate with and complement the ACR TI-RADS classification system, allowing for more accurate diagnosis o...

What is the current status of trial NCT04614389?

This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2019-09-04. Estimated completion is 2021-07-07.

What interventions are being tested in trial NCT04614389?

The interventions under investigation include: Contrast-enhanced ultrasound (OTHER), Shear Wave Elastography (OTHER), Sequoia System (DEVICE).

Who is sponsoring clinical trial NCT04614389?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04614389's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04614389, the US trial registry maintained by the National Library of Medicine. NCT04614389 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.